ProUroCare Medical Inc. (PUMD)

Market Cap	1.86K -98.1%
Revenue (ttm)	n/a
Net Income	-2.11M
EPS	-0.12
Shares Out	18.60M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	6,137
Open	0.0001
Previous Close	n/a
Day's Range	0.0001 - 0.0001
52-Week Range	0.0001 - 0.0002
Beta	18.50
RSI	n/a
Earnings Date	n/a

About ProUroCare Medical

ProUroCare Medical Inc. engages in developing products for the detection and characterization of male urological prostate disease. It offers the ProUroScan System, a prostate imaging system that aids the physician in documenting abnormalities in the prostate that have been previously detected by a digital rectal exam. The company has licensing, development, and commercialization agreements with Artann Laboratories Inc. for its ProUroScan System. ProUroCare Medical Inc. was founded in 1999 and is based in Eden Prairie, Minnesota.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: PUMD